Targeting RPS2P51: A Potential Therapeutic Approach for Various Diseases

Target Name: RPS2P51

NCBI ID: G729679

RPS2P51

Other Name(s): RPS2_25_1632 | Ribosomal protein S2 pseudogene 51 | ribosomal protein S2 pseudogene 51

Targeting RPS2P51: A Potential Therapeutic Approach for Various Diseases

RPS2P51 (RPS2P51) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is Rho GTPase-activating protein 2 (RGAP2), and it is a member of the Rho GTPase family. RGAP2 is involved in the regulation of cellular processes that are essential for the development, maintenance, and survival of tissues.

The Rho GTPase family is a large family of proteins that are characterized by the presence of a catalytic GTPase activity and a regulatory protein activity. These proteins play a crucial role in the regulation of cellular processes, including cell growth, differentiation, and survival. RGAP2 is a member of this family and is involved in the regulation of various cellular processes.

Drugs that target RPS2P51 may have a therapeutic effect on a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. As a drug target, RPS2P51 may be a valuable target for the development of new therapies for these diseases.

Targeting RPS2P51

RPS2P51 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is Rho GTPase-activating protein 2 (RGAP2), and it is a member of the Rho GTPase family. RGAP2 is involved in the regulation of cellular processes that are essential for the development, maintenance, and survival of tissues.

The Rho GTPase family is a large family of proteins that are characterized by the presence of a catalytic GTPase activity and a regulatory protein activity. These proteins play a crucial role in the regulation of cellular processes, including cell growth, differentiation, and survival. RGAP2 is a member of this family and is involved in the regulation of various cellular processes.

RPS2P51 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is Rho GTPase-activating protein 2 (RGAP2), and it is a member of the Rho GTPase family. RGAP2 is involved in the regulation of cellular processes that are essential for the development, maintenance, and survival of tissues.

The Rho GTPase family is a large family of proteins that are characterized by the presence of a catalytic GTPase activity and a regulatory protein activity. These proteins play a crucial role in the regulation of cellular processes, including cell growth, differentiation, and survival. RGAP2 is a member of this family and is involved in the regulation of various cellular processes.

Targeting RPS2P51

RPS2P51 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is Rho GTPase-activating protein 2 (RGAP2), and it is a member of the Rho GTPase family. RGAP2 is involved in the regulation of cellular processes that are essential for the development, maintenance, and survival of tissues.

The Rho GTPase family is a large family of proteins that are characterized by the presence of a catalytic GTPase activity and a regulatory protein activity. These proteins play a crucial role in the regulation of cellular processes, including cell growth, differentiation, and survival. RGAP2 is a member of this family and is involved in the regulation of various cellular processes.

Targeting RPS2P51 may have a therapeutic effect on a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. As a drug target, RPS2P51 may be a valuable target for the development of new therapies for these diseases.

The Potential therapeutic effects of targeting RPS2P51 may be achieved through the use of small molecules, antibodies, or other therapeutic agents that can modulate the activity of RGAP2. These therapeutic agents may be used to

Protein Name: Ribosomal Protein S2 Pseudogene 51

The "RPS2P51 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS2P51 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets